Showing all 3 results
Desvenlafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base)50 mg (ER) The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. Desvenlafaxine Succinate USP/Ph.Eur. 100 mg (ER) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).
Mirtazapine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the tetracyclic compound.
Active Ingredient Strength Primary Clinical Function Mirtazapine Ph.Eur./USP 15 mg Initiation / Maximum Sedation Standard: Base unit. (Clinical Quirk: Due to histamine saturation, the 15mg dose is actually MORE sedating than the higher doses, making it the primary choice for severe insomnia.) Mirtazapine Ph.Eur./USP 30 mg / 45 mg Global Psychiatry Standard: High-efficacy adult maintenance therapy for severe Major Depressive Disorder (MDD). At these doses, increased norepinephrine release counteracts some of the histamine-induced sedation. Excipients Microcrystalline Cellulose / Crospovidone / Mannitol / Aspartame / Magnesium Stearate / Premium Flavoring Diluent / Superdisintegrant / Sweetening Agent / Lubricant (Engineered specifically for rapid gastric or sublingual dissolution, heavily utilizing artificial sweeteners and flavors to completely mask the intensely bitter API for geriatric compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Paroxetine Tablets (CR)
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the extended-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 12.5 mg (CR) Initiation Standard: Base titration unit to safely acclimatize the brain and minimize initial side effects. Gold standard for PMDD. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 25 mg (CR) Global Clinical Standard: Standard adult maintenance dose for Major Depressive Disorder and Severe Panic Disorder. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 37.5 mg (CR) Advanced Psychiatric Standard: High-dose maintenance therapy for treatment-resistant depression and refractory anxiety. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Lactose Monohydrate / Magnesium Stearate / Triethyl Citrate Hydrophilic SR Polymer Matrix / Enteric Coating / Diluent / Plasticizer (Engineered to absolutely block stomach acid and control the exact 24-hour intestinal diffusion rate) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
